Publication Alert: Survodutide in adults with obesity and metabolic dysfunction–associated steatotic liver disease: SYNCHRONIZE®-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial, Ph III Primary results
Lee M Kaplan, Elena Startseva, Carel W. le Roux, Sean Wharton et autres